motor stimulating (GMS) activity even after being converted to its metabolites PI and P2 in dogs. These metabolites were isolated from dog liver using a series of chromatographic procedures. Their structures were determined to be the 15-and 14-hydroxyl derivatives of EM574, respectively, by spectral analysis. Large scale preparation by microbial transformation was investigated for further evaluation of the metabolites, because the amounts obtained by oxidation with dog liver homogenate were limited.
variesporum IFO 14104 and Nocardia capreola IFO 12847, were found to have the aiming oxidative potency. HPLCanalysis of the crude extracts from these three cultures showedthat the bioactive metabolites, EM574 PI and P2 were produced. They were isolated from the culture broth with the other bioactive products EM574P3 and P4. These bioactive products were prepared by large scale cultivation. EM574P3 and P4 showed GMSactivity comparable to that of EM574 PI and P2. The structures of EM574P3 and P4 were elucidated by spectral analysis and found to be the 3"-0-demethyl derivatives of EM574P2 and EM574,respectively. Moreover, the absolute configuration at the C14 position of P2 was determined to be R by spectral analysis of the 6-membered cyclic carbonate of EM574P2.
Erythromycin (EM) has been recognized to have prokinetic activities in addition to antibacterial activities. Its action resembles that of a gastrointestinal hormone, motilin. 1~4) Recent findings have provided evidence that EMis a motilin receptor agonist.5~7) Accordingly, these evidences shed light on EMderivatives as promising new prokinetic drugs. Investigations on EM derivatives developed two motilides, EM574 (1) and EM523 (2), which showed stronger gastrointestinal motor stimulating (GMS) activity than EMA without antibacterial activities.8>9) However, the plasma levels of the agents were very low upon oral or intraduodenal administration in dogs and all of proposed metabolites did not have enough activity to explain the strong activity. These observations suggested that unknown"bioactive metabo- AUG. 1996 lites" might be responsible for the GMSactivity. Two bioactive metabolites, PI and P2, were isolated from dog liver by chromatographic procedures as detected by contractile activity using an isolated rabbit duodenum.Their structures were determined to be the extracts derived from these three strains. A. tolypophorus and D. variesporum were found to produce 4, and N. capreola was found to produce both 3 and 4.
In the case of N. capreola, the optimal incubation period was found to be 4~6 hours after the addition of 1. The seed culture was transferred to the media and incubated at 28°C for 24 hours. The culture broth thus obtained was mixed with 1L followed by incubation for 6 hours. The broth was purified according to the procedure10) for the isolation of 3 and 4 from the liver homogenateto give a crude powder. This was subjected to silica gel chromatography to afford crude powders of 3 and 4, respectively. These were purified by preparative HPLC (ODS, methanol or acetonitrile in phosphate buffer; pH 4.0) to give 3 and 4, respectively. As a result, 3 and 4 (total yield 9.5%) were isolated from the culture broth of N. capreola. In the case of D. variesporum, the optimal incubation period was found to be 24 hours after the addition of 1. Thecultivation and isolation were carried out in the same procedure as in the case of N. capreola. Fromthe broth, 4 (yield 3.0%) was isolated. In the case ofA. tolypophorus, the optimal incubation period was found to be 20 hours after the addition of1. From the broth ofA. tolypophorus, 4 (yield 20%) was isolated.
The Unique Metabolites in Microbial Conversion
Prokaryotes, such as bacteria and actinomycetes, possibly have a metabolic system different from that of eukaryotes, such as fungi and mammals. For example, in the oxidative metabolism by cytochrome P450, the former demands NAD,12) the latter requires NADP. Therefore, actinomycetes might convert 1 to unique metabolites of their own. The metabolic products of the three strains were subjected to preparative HPLC(ODS, solvent B). All the fractions were subjected to the contraction assay. 10) The products of A. tolypophorus gave no bioactive fraction but that of 4. On the other hand, the extracts from D. variesporum contained bioactive fractions at THE JOURNAL OF ANTIBIOTICS retention times (Rt) 5-6 and 13 -14 minutes along with that of 4 (Rt 7-8 minutes). The conversion mixture of N. capreola contained a bioactive fraction at Rt 5-6 minutes accompanied by those of 3 and 4. On analytical HPLC(ODS, solvent B) with detection by UVabsorption at 214nm,the unknownbioactive fractions corresponded to the peaks at Rt 5.3 and 14.0 minutes. They were designated EM574 P3 (7) and P4 (8), and purified by silica gel and preparative HPLC(ODS) from the crude extracts of the two strains. Fromthe culture broth of D. variesporum (mentioned above) 7 and 8 were obtained as white powders along with 4 (total yield 9.0%). In that of N. capreola (mentioned above) 7 was detected, along with 3 and 4. Substrate 2 was converted by N. capreola and analyzed in the same manner as described above. EM523 PI (5), EM523 P2 (6) and EM523 P3 (9) were detected in the crude extract by HPLCanalysis.
Preparation of the Metabolites in Large Scale Cultivation The production process described above was carried out on a large scale with a 200-liter fermenter. In this case, the substrate was supplied as an 80% ethanol solution. The crude products were purified by combinations of silica gel and HP-20 chromatography and preparative HPLC(ODS). As a result, from the culture broth ofD. variesporum, 4, 7 and 8 (total yield ca. 3%) were obtained. From that of N. capreola, 3, 4 and 7 were obtained in a ca. 4%yield totally. From that of N. capreola fed on 2, 5, 6 and 9 were obtained in a ca. 8.5% yield totally. However, in the culture mixture of D. variesporum fed on 2, 6 and 9 were produced but not EM523P4. Yields of the products in these cultures are summarized in Table 2 .
The Structures of P3 and P4 In the NMRspectra, 7 and 8 showed no 3"-0-methyl signal. Along with this, the chemical shifts of Cl", C2" and C3" changed by 2-6ppm in the 13C NMRspectra. Apart from these changes, the other signals of 7 and 8 were nearly the same as those of 4 and 1, respectively. The UVand IR spectra of 7 and 8 were very similar to those of 1. The molecular ion peaks (MH+) of7 and 8 were detected at 730 and 746, respectively, in the SI-MS, indicating that they decreased from those of 4 and 1 by 14 mass units (corresponding to one CH2). Therefore, 7 and 8 were concluded to be the 3"-<9-demethyl derivatives of4 and 1, respectively. The structure of9 was determined to be the 3"-<9~demethyl derivative of 6 in the same way. The structures are shownin Fig. 1 , and the 13C NMRspectral data for all the bioactive metabolites 805 and the substrates are listed in Table 3 .
Absolute Configuration at the C14 Position of P2 The structures of PI, P2, P3 and P4 were determined except for the absolute configuration at the C14 position of P2 and P3. Even with the intensive NMRspectroscopic analysis of 4, the configuration at the position remained uncertain. Being overlapped by other signals, the 14-H signal could not be distinguished from the others in the NOEexperiment. Therefore, 4 was converted to corresponding 6-membered cyclic carbonate. 3. 16ppm). The 2'-carbamate seems so unstable as to have been hydrolyzed during the work up. When.4"-OH of 4 was converted to 4"-carbamate 4a and 4b, the chemical shifts of C4" and 4"-H showed down field shifts from 3C 78.0 and 8H 3.06 to 8C 83.4 and <5H 4.88 (4a) and to 8C 83.3 and <5H 4.81ppm (4b). In the *H NMRspectra of 4a, the ll-H was observed at 3 5.30ppm, showing a 1.88ppm down field shift from 3 3.42ppm, while 14-H was at 3 4.46ppm showing only a 0.36ppm down field shift from 8 4.10ppm. This indicated that ll-OH was converted to 1 1-carbamate and the cyclic carbonate was formed over C12 and C14. On the other hand, 4b showed 14-H at 8 5.51 ppm and ll-H at 8 4.23ppm indicating that 14-OHwas substituted by the carbamate and the carbonate was formed over Cl l and C12. The structures of4a and 4b are illustrated in Fig. 2 . As for the reactivity in the acylation reaction, the 14-hydroxyl group of 4 seems as reactive as the 1 1-hydroxyl group. Concerning the determination of the configuration at C14, information from the NMRdata of 4a was very helpful. In the XH NMRspectrum of4a, 13-H was observed at 3 4.77ppm as a doublet (/= 10.1 Hz) showing a coupling with 14-H (S 4.66ppm, double quartet, /=10.1, 6.3Hz). The coupling constant (10.1Hz) indicated that two protons located in the 1,2-diaxial position on the 6-membered cyclic carbonate ring as shown in Fig. 3 . This means the absolute configuration atC14 to be "R".
Biological Activities
The contractile activity10) in isolated rabbit duodenum (in vitro) and GMSactivity10) (in vivo) of the obtained products are summarizedin Table 3 . All the metabolites showed activity comparable to that of the parent compound in the in vitro assay. On the other hand, except for 9, they exhibited 2-to 4-fold stronger GMSactivity than 1 and 2 in vivo.
Discussion
Here we have described the microbial production of 14-and 15-hydroxyl derivatives of EM574 and EM523. AUG. 1996 The bioactive metabolites 3 and 4 were detected in the plasma after oral administration of [14C]-labeled 1 to dogs,1 1} and therefore, the significance of the metabolites has become of greater interest. The main products, 14-hydroxyl derivatives (4 and 6), were obtained in sufficient amounts for further pharmaceutical investigation, while the yields for the 15-hydroxyl derivatives (3 and 5) were very low. The production utilized the three strains of actinomycetes for giving the metabolites in different yield from one another. It is quite interesting that such oxidative activity is observed in these strains belonging to the rare actinomycetes.
On the other hand, the 3"-0-demethyl derivatives, P3 and P4, were isolated as unique microbial products. As the substrate for microbial conversion, 1 and 2 show some different characteristics.
EM523gave only a small amount of PI and didn't give P4 even on a cultivation scale of 200 liters, while EM574gave P1~P4 to some extent. EM574 and EM523 differ only in the 3r-7V-alkyl group. This difference causes a slight change in the C14/1 5 position, but the alkyl group should affect the oxidation at the 3"-<9-position. It may be speculated that the alkyl group occupies the space near to the 3"-(9-methyl group as shown in Fig. 3 . VOL.49 NO.8
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The absolute configuration at the C14 position of EM574P2 was determined to be "R" by converting the cyclic carbonate 4a. As the metabolites of erythromycin derivatives in humans, 14-hydroxy-6-0-methylerythromycin A14) has been reported. The stereochemistry at the C14 position of the major metabolite (M-5) was elucidated to be "R", and that of the minor one (M-6) was found to beå "S". In the microbial (Mucor species) transformation of 6-0-methylerythromycin derivatives,1 5) only (147?)-14-hydroxy-6-0-methylerythromycin A and B were isolated. These results partially agree with our results. Wecouldn't isolate "S"-derivatives having GMSactivity in the microbial conversion, while the conversion using dog liver homogenates afforded the 14-and 15-hydroxyl derivatives in nearly the same yields.10)
This might mean that microorganisms, including actinomycetes and Mucor oxidize erythromycintype antibiotics stereo-and regio-selectively at the C14 position.
Experimental

Measurement of Physico-chemical Data
The UV spectra were measured at 23~28°C in methanol. The IR spectra were measured in KBr pellets using a Horiba FT-200 instrument. The SI-MS spectra were measured on a Hitachi M-80Ainstrument using glycerol as the matrix. The NMR spectra were measured in deuterochloroform. The^-values in the NMRspectra were recorded in ppm down field from tetramethylsilane (TMS) as the external standard using a Bruker AC-300 spectrometer.
Preparation of Seed Cultures of Actinomycetes
Each actinomycete grown on a yeast extract-malt extract agar slant was inoculated into a 200-ml Erlenmeyer flask containing a mediumconsisting of glucose 1%, tryptone 1% and yeast extracts 0.6% (40ml, pH 7.0) and shaken on a reciprocal shaker at 28°C for 24 hours. Five-milliliter portions of the resulting culture fluid were dispensed into test tubes and frozen at -80°C as the working stock. The stock was thawed at room temperature, and a 1-ml portion was transferred to a 200-ml Erlenmeyer flask containing 40 ml of the medium and shaken on a reciprocal shaker at 28°C for 24 hours to obtain the seed culture fluid.
Preparation of 3 and 4 by N. capreola (flask scale)
One-milliliter portions of the seed culture of N. capreola IFO 12847 were transferred to a 200-ml
Erlenmeyer flask containing 40ml of the medium and shaken on a reciprocal shaker at 28°C for 24 hours.
Compound 1L (6mg/ml in water, 1.0ml) was added to each flask and incubated at 28°C for 6 hours. The obtained culture broth (3.0 liters) was centrifuged at 4°C and 8000 rpm for 10 minutes. The supernatant (2.8 liters) was adjusted to pH 7.0 and subjected to Diaion HP-20 collected and concentrated to give crude powders of 4 (lll mg) and 3 (45mg), respectively. The former was subjected to preparative HPLC (column: YMC-Pack, D-ODS-5, YMC, Japan, mobile phase: 55% MeOH-0.02 m phosphate buffer; pH 4.0). The latter was subjected to prep. HPLC (28% acetonitrile-0.02M phosphate buffer). The fractions of 4 and 3 were independently collected, adjusted to pH 7.4, concentrated to about 20ml, adjusted to pH 8.5 and extracted with EtOAc (12ml) three times. The organic layers were combined, washed with saline, dried over anhydrous sodium sulfate and evaporated to give powders of 4 (43mg) and 3 (4.3 mg), respectively (total yield, 9.5%).
UV: 4, Xmax 207nm (e 7700), IR: 4, 3460, 2970 IR: 4, 3460, , 2940 IR: 4, 3460, , 1740 IR: 4, 3460, , 1640 IR: 4, 3460, , 1460 IR: 4, 3460, , 1380 IR: 4, 3460, , 1330 IR: 4, 3460, , 1270 IR: 4, 3460, , 1170 IR: 4, 3460, , 1100 IR: 4, 3460, , 1060 IR: 4, 3460, , 1010 Compound1L (4mg/ml in water, 1.0ml) was added to each flask and incubated at 28°C for 24 hours. The obtained culture broth (9.0 liters) was treated in the samemanner as described in the case of TV. capreola to give a crude powder (896mg). This powder (895 mg) was subjected to silica gel (20g) column chromatography eluting with MeOH-CHCl3to give a mixture of4, 7 and 8 (468mg). This mixture was subjected to prep. HPLC (D-ODS-5, solvent B) to give powders of 4 (43mg), 8 (49mg) and crude 7, respectively. The crude powder of 7 was purified by prep. HPLC (25% acetonitrile-0.02M phosphate buffer, pH 4.0) to give a powder of7 (46mg, total yield, 9.5%).
UV: 7, imax 206nm (e 8500), IR: 3460, 2970 IR: 3460, , 2940 IR: 3460, , 1740 IR: 3460, , 1640 IR: 3460, , 1460 IR: 3460, , 1380 IR: 3460, , 1330 IR: 3460, , 1270 IR: 3460, , 1170 IR: 3460, , 1110 IR: 3460, , 1060 IR: 3460, , 1010 Compound 2 (8mg/ml in 80% EtOH, 0.5ml) was added to the flask and incubated at 28°C for 4 hours. The obtained culture broth (40ml) was treated in the same manner as described in the case of N. capreola to give a crude powder (4.0mg). This powder was analyzed by HPLC (ODS; A-312, 25% acetonitrile-0.02 M phosphate buffer; pH 4.0) and determined to contain 5 (46 mg) and 6 (2.0mg).
In another experiment, 9 was detected (7/xg/ml) in the culture broth obtained in the same manner.
Preparation of Seed Cultures for Large Scale Cultivation The frozen stock was thawed at room temperature, and a 5-ml portion was transferred to a 2-liter Sakaguchi flask containing 500 ml of the medium. The mixture was shaken on a reciprocal shaker at 28°Cfor 24 hours to obtain the seed culture fluid. Sweden) column chromatography eluting with MeOHto give powder-III (506mg). Powder-II and -III were each subjected to prep. HPLC (ODS, YMC-Pack S-363 1-15) eluting with 30% acetonitrile-0.02m phosphate buffer (pH 4.0). The fractions containing 4 and a mixture of 7 and 8 were independently collected, adjusted to pH 7.4, concentrated, adjusted to pH 8.5 and extracted with EtOActhree times. The organic layers were combined, washed with saline, dried over anhydrous sodium sulfate and evaporated to give powders of 4 (104mg) and a mixture of 7 and 8. The mixture was subjected to prep. HPLC(D-ODS-5) eluting with 25% acetonitrile-0.02 M phosphate buffer (pH 4.0). The fractions containing 7 and 8 were independently treated in the same manner to give powders of 7 (129mg) and 8 (133mg), respectively (total yield, ca. 3%).
Preparation of 3, 4 and 7 by N. capreola (fermenter scale)
The seed culture fluid of N. capreola was transferred and cultured in the same manner as described in the case ofD. variesporum for 24 hours. A solution of 1 (16 mg/ml in 80% EtOH, 750ml) was added to the fermenter and then incubated for 6 hours. The obtained culture broth (120 liters) was treated in a manner similar to that described above to give a crude powder (6.1g). This powder was subjected to silica gel column chromatography (150 g) eluting with MeOH-CHCl3. The fractionselutedwithMeOH-CHC13 (2 :98-5 : 95 and 5 :95) were independently collected and concentrated to give powder-I (2.55g) and powder-II (1.59g), respectively.
Powder-I and -II were each purified by mesh, 100 and 50ml) column chromatography eluting with 80% MeOHin 5mMHC1. The eluates were concentrated and extracted with EtOAcat pH 8.5, and the organic layers were dried and evaporated to give powder-la (1.58g) and -Ila (722mg), respectively.
Powder-la and -Ila were each subjected to prep. HPLC (ODS, YMC-Pack SH-363-15, S-15) eluting with 30%
